Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Maini
Adarsh Maini, Strasburg, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110165107 | Volume up shampoos - The invention relates to aqueous compositions comprising an anionic surfactant and a hyperbranched polyesteramide having at least one quarternized amine end-group. The compositions, in particular in the form of shampoo preparations are suited for increasing the volume of hair treated therewith. Furthermore, such compositions provide styling attributes and increase the wet-combability of hair. | 07-07-2011 |
Adarsh Maini, Stephens City, VA US
| Patent application number | Description | Published |
|---|---|---|
| 20110182843 | Volume Up Shampoos II - The invention relates to aqueous compositions comprising an anionic surfactant and a hyperbranched polyesteramide comprising at least one secondary amide bond and having at least one quarternized amine end-group. The compositions, in particular in the form of shampoo preparations are suited for increasing the volume of hair treated therewith. Furthermore, such compositions provide styling attributes and increase the wet-combability of hair. | 07-28-2011 |
Chetan Kumar Maini, Karnataka IN
| Patent application number | Description | Published |
|---|---|---|
| 20120059526 | System and Method for Monitoring and Controlling Energy System - A method and system for identifying at a remote location provide at least one condition associated with an energy system ( | 03-08-2012 |
Chetan Kumar Maini, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20110196560 | Antilock Braking For Vehicles - The invention provides a method and a system for enabling antilock braking in a vehicle which is propelled at least by an electric motor. The method includes detecting tendency of locking of the at least one wheel by comparing actual rate of change of speed of the at least one of the motor, wheels, transmission, shaft and ground speed with expected rate of change of speed of at least one wheel, wherein the vehicle is being decelerated. Based on the tendency of locking at least regenerative braking is modulated to prevent locking of at least one wheel of the vehicle. | 08-11-2011 |
| 20120059766 | Method and System for Revenue Generation Using Energy System - A method and a system for determining compensation to be paid for using any one of an energy storage system and an energy system are provided. The energy system is at least partially powered by electricity stored in the energy storage system. The method includes, determining the amount of consumption of electric energy from the energy storage system during a period of usage, and determining the carbon credit associated with the energy storage system or the energy system during the usage. Thereafter, the compensation is calculated based on the amount of consumption of the electric energy and the carbon credit. | 03-08-2012 |
| 20120150378 | Determination and Usage of Reserve Energy in Stored Energy Systems - A method and system for determining amount of internal reserve energy that is available in an energy storage system is provided. The method includes determining capacity of the energy storage system to store energy and computing the amount of internal reserve energy available below a threshold level based on the determined capacity. Further, state of health of the energy storage system is determined based on historical data that is collected. Additionally, current state of the energy storage system is determined. The state of health of the energy storage system and current state of the energy storage system is used to refine the amount of internal reserve energy. | 06-14-2012 |
Enrico Maini, Santa Maria Della Versa IT
| Patent application number | Description | Published |
|---|---|---|
| 20120178907 | PROCESS FOR PRODUCING INSTANTANEOUS COLD SOLUBLE GELATIN AND PRODUCT THEREOF - Process for producing instantaneous cold soluble gelatin in form of agglomerates of gelatin granules carried out in a fluid bed under controlled temperature, which comprises soaking the gelatin granules through atomising a granulating liquid in the fluid bed, where the granulating liquid is made up of water. | 07-12-2012 |
Kamaljeet Maini, Houston, TX US
| Patent application number | Description | Published |
|---|---|---|
| 20100293364 | Device Software Customization - Systems, methods, and other embodiments associated with device software configuration are described. One example method is executed by a personal electronic device (PED) having a read only memory (ROM) configured with a boot loader, a BASE ROM partition, and a customization file store partition (CFSP). The method includes receiving a customization package and storing it in the CFSP. The method includes invoking a one-time installation process to customize PED software, settings, characteristics, and so on, based on the CFSP contents. The method includes invoking a boot-time installation process to configure a file system filter driver on the PED to control access to CFSP contents based, at least in part, on a file attribute associated with the CFSP content. | 11-18-2010 |
Mala K. Maini, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20100040632 | COMPOSITION - The present invention relates to a method of treating liver damage, especially hepatitis B virus (HBV) related liver damage. The present invention also relates to compositions and kits for use in treating liver damage. | 02-18-2010 |
Michele Maini, Santa Maria Della Versa IT
| Patent application number | Description | Published |
|---|---|---|
| 20120178907 | PROCESS FOR PRODUCING INSTANTANEOUS COLD SOLUBLE GELATIN AND PRODUCT THEREOF - Process for producing instantaneous cold soluble gelatin in form of agglomerates of gelatin granules carried out in a fluid bed under controlled temperature, which comprises soaking the gelatin granules through atomising a granulating liquid in the fluid bed, where the granulating liquid is made up of water. | 07-12-2012 |
Paolo Dario Maini, Monza (mi) IT
| Patent application number | Description | Published |
|---|---|---|
| 20110220228 | ARM TO DISTRIBUTE CONCRETE AND RELATIVE PRODUCTION METHOD - An arm to distribute concrete comprising a plurality of articulated segments selectively able to be folded back and extended with respect to each other, made of composite material, wherein at least one of said segments comprises at least a first tract and a second tract, each having a constant cross section, wherein the section size of the first tract is different from the section size of the second tract, a connection tract being provided between said first tract and said second tract. | 09-15-2011 |
Paolo Dario Maini, Monza IT
| Patent application number | Description | Published |
|---|---|---|
| 20100282701 | ARM MADE OF COMPOSITE MATERIAL AND RELATIVE PRODUCTION METHOD - An arm made of composite material, and relative production method, consisting of a plurality of articulated segments with a longitudinal main axis (x), pivoted to each other, each of the articulated segments comprising a box-like structure and at least a joint element attached thereto by means of gluing, the box-like structure having an end cooperating with an end of the joint element on the inside of the surface of the joint element. The ends define a substantially conical reciprocally overlapping area and have profiles concordantly inclined by an angle (α) with respect to the longitudinal axis (x). | 11-11-2010 |
Ravinder N. Maini, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090263388 | Methods of preventing or treating cardiovascular, cerebrovascular and thrombotic disorders with tumor necrosis factor antagonists - A method of treating or preventing a cardiovascular and/or a cerebrovascular disorder in an individual is disclosed. Also disclosed is a method for treating and/or preventing a thrombotic disorder in an individual. Further disclosed is a method of decreasing plasma fibrinogen in an individual. | 10-22-2009 |
| 20110014188 | TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease - Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. | 01-20-2011 |
| 20110123543 | TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease - Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. | 05-26-2011 |
| 20120141474 | TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease - Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. | 06-07-2012 |
| 20120141475 | TNF-alpha Antagonists and Methotrexate in the Treatment of TNF-Mediated Disease - Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. | 06-07-2012 |
Ravinder Nath Maini, London GB
| Patent application number | Description | Published |
|---|---|---|
| 20090175859 | TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease - Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation. | 07-09-2009 |
Revinder Nath Maini, Barnes GB
| Patent application number | Description | Published |
|---|---|---|
| 20090181029 | Methods for treating interleukin-6 related diseases - A pharmaceutical composition for the treatment of interleukin-6 (IL-6) related diseases, comprising an interleukin-6 antagonist (IL-6 antagonist) and immunosuppressants. The IL-6 antagonist is preferably an antibody to an interleukin-6 receptor (IL-6R). | 07-16-2009 |